Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Fayetteville, NC Accepting Medicare

3 Thoracic Surgery (Cardiothoracic Vascular Surgery) doctors found. Showing 1 - 3

Robert E Maughan, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2153 Valleygate Dr, Suite 101, Fayetteville, NC 28304 Phone: 910-672-0350

Dr. Gregory Stephen Keagy, DO Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 2153 Valleygate Dr, Suite 101, Fayetteville, NC 28304 Phone: 910-672-0350    Fax: 910-672-0355

John C Alexander, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-615-5610    Fax: 910-615-5080

News Archive

Study indentifies unmet medical need for treatment of patients with chronic pain and dysphagia

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the completion of a research study, conducted with an independent market research firm, that identified a significant unmet medical need for improved treatments for patients with chronic pain and dysphagia/odynophagia. In clinical practice, dysphagia is most often defined as difficulty in swallowing and odynophagia is defined as pain upon swallowing.

Study provides new insights into how the human immune system protects against Ebola infections

Two types of human antibodies that target different parts of the Ebola virus synergize their antiviral effects by inhibiting different steps of infection, according to a study published August 23 in the open-access journal PLOS Pathogens by Philipp Ilinykh and colleagues from the University of Texas Medical Branch, Vanderbilt University, and Ragon Institute.

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.

China Botanic first quarter net sales increase 24.4% to $28.1M

China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines in China, today announced financial results for the three months ended January 31, 2012.

MabVax closes $11.6 million in private placement

MabVax Therapeutics Holdings, Inc., a clinical-stage cancer immunotherapy company, is pleased to announce that it has closed on gross proceeds of approximately $11.6 million in a private placement (the "Private Placement") led by OPKO Health, Inc. and Dr. Phillip Frost, CEO and Chairman of OPKO Health.

Read more Medical News

› Verified 8 days ago